Cargando…
Updates on Treatment of Attention-Deficit/Hyperactivity Disorder: Facts, Comments, and Ethical Considerations
Within the last 2 years the bulk of information on evidence based treatments in ADHD was reviewed quite intensively and new empirical studies could be added. This update reports comprehensively about actual and essential facts in the field related to brain development and sensitive periods, predicto...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501189/ https://www.ncbi.nlm.nih.gov/pubmed/22968494 http://dx.doi.org/10.1007/s11940-012-0197-2 |
_version_ | 1782250167999660032 |
---|---|
author | Rothenberger, Aribert Rothenberger, Lillian Geza |
author_facet | Rothenberger, Aribert Rothenberger, Lillian Geza |
author_sort | Rothenberger, Aribert |
collection | PubMed |
description | Within the last 2 years the bulk of information on evidence based treatments in ADHD was reviewed quite intensively and new empirical studies could be added. This update reports comprehensively about actual and essential facts in the field related to brain development and sensitive periods, predictors of treatment, safety of medication, value of naturalistic studies, new drugs and complementary medicine, behavioral interventions including neurofeedback and psychosocial treatment, treatment of comorbidity, and ethical considerations including preventive aspects. The updated combination of well selected evidence based treatments (ie, pharma plus non-pharma) seems to be clinically and ethically recommended as also suggested by the European and American guidelines on ADHD. |
format | Online Article Text |
id | pubmed-3501189 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Current Science Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-35011892012-11-26 Updates on Treatment of Attention-Deficit/Hyperactivity Disorder: Facts, Comments, and Ethical Considerations Rothenberger, Aribert Rothenberger, Lillian Geza Curr Treat Options Neurol Pediatric Neurology (Hs Singer, Section Editor) Within the last 2 years the bulk of information on evidence based treatments in ADHD was reviewed quite intensively and new empirical studies could be added. This update reports comprehensively about actual and essential facts in the field related to brain development and sensitive periods, predictors of treatment, safety of medication, value of naturalistic studies, new drugs and complementary medicine, behavioral interventions including neurofeedback and psychosocial treatment, treatment of comorbidity, and ethical considerations including preventive aspects. The updated combination of well selected evidence based treatments (ie, pharma plus non-pharma) seems to be clinically and ethically recommended as also suggested by the European and American guidelines on ADHD. Current Science Inc. 2012-09-12 2012 /pmc/articles/PMC3501189/ /pubmed/22968494 http://dx.doi.org/10.1007/s11940-012-0197-2 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Pediatric Neurology (Hs Singer, Section Editor) Rothenberger, Aribert Rothenberger, Lillian Geza Updates on Treatment of Attention-Deficit/Hyperactivity Disorder: Facts, Comments, and Ethical Considerations |
title | Updates on Treatment of Attention-Deficit/Hyperactivity Disorder: Facts, Comments, and Ethical Considerations |
title_full | Updates on Treatment of Attention-Deficit/Hyperactivity Disorder: Facts, Comments, and Ethical Considerations |
title_fullStr | Updates on Treatment of Attention-Deficit/Hyperactivity Disorder: Facts, Comments, and Ethical Considerations |
title_full_unstemmed | Updates on Treatment of Attention-Deficit/Hyperactivity Disorder: Facts, Comments, and Ethical Considerations |
title_short | Updates on Treatment of Attention-Deficit/Hyperactivity Disorder: Facts, Comments, and Ethical Considerations |
title_sort | updates on treatment of attention-deficit/hyperactivity disorder: facts, comments, and ethical considerations |
topic | Pediatric Neurology (Hs Singer, Section Editor) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501189/ https://www.ncbi.nlm.nih.gov/pubmed/22968494 http://dx.doi.org/10.1007/s11940-012-0197-2 |
work_keys_str_mv | AT rothenbergeraribert updatesontreatmentofattentiondeficithyperactivitydisorderfactscommentsandethicalconsiderations AT rothenbergerlilliangeza updatesontreatmentofattentiondeficithyperactivitydisorderfactscommentsandethicalconsiderations |